Dr Claire Harrison

Dr Claire Harrison is an internationally renowned Consultant Haematologist and Professor specialising in haematological oncology, with a primary focus on blood cancers and rare haematological disorders. She is widely recognised for her work in diagnosing and managing myeloproliferative neoplasms, offering reassuring, evidence-based care tailored to each patient's unique circumstances. Through her leadership in national and global clinical trials, Dr Harrison provides patients with access to innovative therapeutic approaches designed to improve treatment outcomes and enhance quality of life.

Dr Harrison completed her medical degree at Oxford University Medical School, subsequently undertaking postgraduate training across prestigious university teaching institutions. She holds advanced academic degrees, including a Doctor of Medicine (DM). She is a Fellow of the Royal College of Physicians (FRCP) and a Fellow of the Royal College of Pathologists (FRCPath). Maintaining an active role in the broader medical community, Dr Harrison contributes to prominent professional organisations, including the British Society for Haematology and the European Haematology Association, and serves as a trustee for patient advocacy charities dedicated to supporting individuals with blood cancer.

In her clinical practice, Dr Harrison specialises in complex blood disorders, with expertise in essential thrombocythaemia, polycythaemia vera, myelofibrosis, and related overlap conditions. She has been instrumental in advancing the use of targeted biological therapies, including Janus kinase (JAK) inhibitors and novel combination treatments for blood cancers. Dr Harrison is deeply committed to patient-centred care, ensuring patients and their families receive clear guidance, comprehensive support, and personalised treatment plans throughout their medical care.